PCM
GH icon

Penserra Capital Management’s Guardant Health GH Stock Holding History

Penserra Capital Management’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-15,720
Closed -$1.6M – 1133
2025
Q4 		$1.6M Buy
+15,720
New +$1.41M 0.02% 349
2025
Q2 		– Sell
-52,293
Closed -$2.23M – 1069
2025
Q1 		$2.23M Buy
+52,293
New +$2.26M 0.04% 289

Other funds holding GH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Penserra Capital Management's GH Position: Q1 2026 in Review

Penserra Capital Management sold out of Guardant Health (GH) in Q1 2026, closing a stake of 15,720 shares — an estimated $1.6M sold.

Penserra Capital Management first reported a position in GH in Q1 2025 and held it in 2 quarters. The position peaked at $2.23M in Q1 2025. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • Penserra Capital Management reported no remaining Guardant Health position as of Q1 2026 after selling out during the quarter.
  • Penserra Capital Management sold 15,720 Guardant Health shares in Q1 2026, an estimated $1.6M.
  • Penserra Capital Management first reported a position in Guardant Health in Q1 2025 and held it in 2 quarters.
  • Penserra Capital Management's Guardant Health position peaked at $2.23M in Q1 2025.
  • 481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Penserra Capital Management's 13F filing for Q1 2026, filed 11 May 2026.